Agios Pharmaceuticals (AGIO) Net Equity Issued and Repurchased (2013 - 2019)

Agios Pharmaceuticals (AGIO) has 6 years of Net Equity Issued and Repurchased data on file, last reported at $277.2 million in Q4 2019.

• Quarterly Net Equity Issued and Repurchased changed N/A year-over-year to $277.2 million in Q4 2019, while the trailing twelve-month figure through Dec 2019 was $277.2 million (down 46.3% YoY) and the FY2019 annual result came in at $277.2 million, down 46.3% from the prior year.
• Net Equity Issued and Repurchased fell to $277.2 million in Q4 2019, from $516.2 million in the prior quarter.
• In the past five years, Net Equity Issued and Repurchased ranged from a high of $516.2 million in Q1 2018 to a low of $141.0 million in Q3 2016.
• A 4-year average of $301.2 million and a median of $273.7 million in 2017 frame the typical range for Net Equity Issued and Repurchased.